Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Capital International Investors AWI Armstrong World Industries Inc 13G/A 6% 2y
Bank of New York Mellon Corp AAXJ iShares Trust 13G 27.24% 2y
Bank of New York Mellon Corp BTCW WisdomTree Bitcoin Fund 13G 13.98% 2y
VANGUARD GROUP INC GTLS Chart Industries Inc 13G/A 10.02% 2y
Benno Fischer SOWG Sow Good Inc. 13G/A 12.2% 2y
BlackRock Inc. CPAY Corpay, Inc. 13G/A 6.9% 2y
JPMORGAN CHASE & CO CELH Celsius Holdings, Inc. 13G/A 5.7% 2y
EIN MARK LIND Lindblad Expeditions Holdings, Inc. 13G/A 6.2% 2y
ARK Investment Management LLC ROKU Roku, Inc 13G/A 10.31% 2y
Politan Capital Management LP MASI Masimo Corp 13D/A 8.9% 2y
Saba Capital Management, L.P. IGA Voya Global Advantage & Premium Opportunity Fund 13D/A 5.48% 2y
GAMCO INVESTORS, INC. ET AL HY Hyster-Yale, Inc. 13D/A 6.75% 2y
Classroom Aggregator, LLC KLTR Kaltura Inc 13D/A 4.9% 2y
Stavros G. Vizirgianakis APYX Apyx Medical Corp 13D/A 5.04% 2y
BAKER BROS. ADVISORS LP INCY Incyte Corp 13D/A 16.3% 2y
Simcoe Capital Management, LLC DFIN Donnelley Financial Solutions, Inc. 13D/A 5.8% 2y
GREYBROOK HEALTH INC. GBNH Greenbrook TMS Inc. Common Shares 13D/A 53.2% 2y
WHITE MOUNTAINS INSURANCE GROUP LTD MAX MediaAlpha, Inc. 13D/A 32.9% 2y
JANUS HENDERSON GROUP PLC ABEO Abeona Therapeutics Inc. 13G 6.1% 2y
Pietro Bersani KRBP Kiromic BioPharma, Inc. Common Stock 13D/A 8.75% 2y
Whitefort Capital Management, LP ABUS Arbutus Biopharma Corp 13D 6.8% 2y
Point72 Asset Management, L.P. CRVS Corvus Pharmaceuticals, Inc. 13G 9.9% 2y
Duquesne Family Office LLC DAKT Daktronics Inc 13G 5.4% 2y
MILLENNIUM MANAGEMENT LLC CCIX Churchill Capital Corp IX 13G 4.1% 2y
NEUBERGER BERMAN GROUP LLC MODN MODEL N, INC. 13G/A 0% 2y
PICTON MAHONEY ASSET MANAGEMENT SLAMF Slam Corp. 13G 11.57% 2y
Allspring Global Investments Holdings, LLC IHD Voya Emerging Markets High Dividend Equity Fund 13G/A 10.98% 2y
PICTON MAHONEY ASSET MANAGEMENT TRTL TortoiseEcofin Acquisition Corp. III 13G/A 0% 2y
Karpus Management, Inc. GLST Global Star Acquisition, Inc. Class A Common Stock 13G/A 4.89% 2y
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO ADM Archer-Daniels-Midland Co 13G/A 6.88% 2y
Karpus Management, Inc. ASCA A SPAC I Acquisition Corp. Class A Ordinary Share 13G/A 0% 2y
MANGROVE PARTNERS IM, LLC PRLH Pearl Holdings Acquisition Corp Class A Ordinary Shares 13G/A 4.82% 2y
Mitchell P. Kopin LUCY Innovative Eyewear Inc 13G 5.9% 2y
Nine Ten Capital Management LLC SSTI Soundthinking, Inc. 13G/A 0% 2y
Magnitude Capital, LLC HG Hamilton Insurance Group, Ltd. 13G/A 26.94% 2y
Fluffco, LLC BOF BranchOut Food Inc. 13G 7.3% 2y
Hilton Hiller Schlosberg MNST Monster Beverage Corp 13D/A 7.4% 2y
Uber Technologies, Inc AUR Aurora Innovation, Inc. 13D/A 27.9% 2y
Uber Technologies, Inc SERV Serve Robotics Inc. 13D 15.2% 2y
Uber Technologies, Inc GRAB Grab Holdings Ltd 13D 14.1% 2y
Politan Capital Management LP MASI Masimo Corp 13D/A 8.9% 2y
Liberty TripAdvisor Holdings, Inc. TRIP TripAdvisor, Inc. 13D/A 21% 2y
Ned L. Sherwood BRN Barnwell Industries Inc 13D/A 29.47% 2y
Uber Technologies, Inc DIDIY DiDi Global Inc. 13D 11.8% 2y
New Enterprise Associates 15, L.P. OKUR OnKure Therapeutics, Inc. 13D/A 14.3% 2y
ACRES Share Holdings, LLC ACR ACRES Commercial Realty Corp. 13D/A 12.14% 2y
Morgan Stephen L. TOMZ TOMI Environmental Solutions, Inc. 13G 5.14% 2y
Dapice Joshua J. EXEL Exelixis, Inc. 13D/A 9.2% 2y
Konstantakopoulos, Konstantinos CMRE Costamare Inc. 13D/A 29% 2y
ORBIMED ADVISORS LLC CRVS Corvus Pharmaceuticals, Inc. 13D/A 11.1% 2y